Sign inJoin waitlistJoin the waitlist

Naomi Haas

Director, Prostate and Kidney Cancer Program · University of Pennsylvania Health System

Credentials: · · · ·

History

University of Pennsylvania Health System
Present
University of Pennsylvania Health System
Present
Perelman School of Medicine at the University of Pennsylvania
Present

Fox Chase Cancer Center
1988–1990
Internal Medicine
Abington Memorial Hospital
1985–1988
Northeast Ohio Med Univ
1981–1985

Research

Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2022 · 571 citations
Safety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancer
Journal of Clinical Oncology · 2004 · 245 citations
A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial
The Lancet · 2021 · 241 citations

Toni Choueiri
8 papers
Vivek Narayan
7 papers · 1 as a fellow
AA
Ajjai Alva
6 papers
Brian Shuch
6 papers
Neeraj Agarwal
6 papers
RM
Robert Motzer
6 papers
AM
Amir Mortazavi
5 papers
Elaine Lam
5 papers
Eric Jonasch
5 papers
GH
Gary Hudes
5 papers
Saby George
5 papers
Brandon Manley
4 papers

Clinical trials

Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC)
Principal investigator · Not yet recruiting
Abramson Cancer Center at Penn Medicine
2026–2028
CART-PSMA-TGFβRDN Cells for Castrate-Resistant Prostate Cancer
Principal investigator · Active not recruiting · Phase 1
University of Pennsylvania
2017–2038
CRLX101 Plus Bevacizumab in Advanced RCC
Principal investigator · Completed · Phase 1
Abramson Cancer Center at Penn Medicine
2012–2018
Pazopanib/DCE-MRIs in Renal Cell Carcinoma (RCC)
Principal investigator · Completed · Early phase 1
Abramson Cancer Center at Penn Medicine
2010–2019